Corona Remedies Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/05/2026 ,inter alia, to consider and approve a) Audited Financial Results on Standalone and Consolidated basis for the Fourth Quarter and Year ended on March 31, 2026;\r\n\r\nb) recommendation of final dividend, if any, on the equity shares of the Company for the financial year ended March 31, 2026, for approval of the shareholders at the ensuing Annual General Meeting.